Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion

Watch Paul and Scarlet LIVE every day on YouTube: . Bloomberg Intelligence hosted by Paul Sweeney, Alexis Christoforous, and Stacey Vanek Smith -Madison Muller, Bloomberg News Health Reporter, discusses news that Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion to establish itself as a leader in other areas and become a major player in infectious diseases. -Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses Quantinuum seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor enthusiasm for quantum computing technology. -Craig Trudell, Bloomberg Managing Editor of Global Business Coverage, discusses Ferrari shares falling almost 8% after critics panned the look of its first fully electric vehicle, a setback for the Italian super-car maker's controversial push into EVs. -Jennifer Bartashus, Bloomberg Intelligence Senior Analyst, Retail Staples & Packaged Food, discusses research: "World Cup's $80 Billion Prize Hinges on Fans Not Crying Foul." FIFA's nearly $9 billion expected revenue take from this year's World Cup may understate the tournament's broader economic impact, with US legal betting alone set to top $2 billion, based on Bloomberg Intelligence's analysis.

You can listen to Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion online on Radio and Podcast. Open the player on this page to stream the available audio.

Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion is an episode from The Tape by Bloomberg.

This episode is 23:12 long.

This episode was published on May 26, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Tape when more episodes are available from the podcast feed.